Diego Arango Del Corro
Grado: Doctor/a
darango(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/M-5667-2016
Grupos
Publicaciones
-
Duarte S; Arango D; Parihar A; Hamel P; Yasmeen R; Doseff AI
Apigenin protects endothelial cells from lipopolysaccharide (LPS)-induced inflammation by decreasing caspase-3 activation and modulating mitochondrial function.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 14 17664-17679. .
-
Mazzolini R; Rodrigues P; Bazzocco S; Dopeso H; Ferreira AM; Mateo-Lozano S; Andretta E; Woerner SM; Alazzouzi H; Landolfi S; Hernandez-Losa J; Macaya I; Suzuki H; Ramón y Cajal S; Mooseker MS; Mariadason JM; Gebert J; Hofstra RM; Reventós J; Yamamoto H; Schwartz S; Arango D
Brush border myosin Ia inactivation in gastric but not endometrial tumors.
INTERNATIONAL JOURNAL OF CANCER 132 1790-1799. .
-
Dávalos V; Súarez-López L; Castaño J; Messent A; Abasolo I; Fernandez Y; Guerra-Moreno A; Espín E; Armengol M; Musulen E; Ariza A; Sayós J; Arango D; Schwartz S
Human SMC2 protein, a core subunit of human condensin complex, is a novel transcriptional target of the WNT signaling pathway and a new therapeutic target.
Journal Of Biological Chemistry 287 43472-43481. .
-
Alhopuro P; Sammalkorpi H; Niittymäki I; Biström M; Raitila A; Saharinen J; Nousiainen K; Lehtonen HJ; Heliövaara E; Puhakka J; Tuupanen S; Sousa S; Seruca R; Ferreira AM; Hofstra RM; Mecklin JP; Järvinen H; Ristimäki A; Orntoft TF; Hautaniemi S; Arango D; Karhu A; Aaltonen LA
Candidate driver genes in microsatellite-unstable colorectal cancer.
INTERNATIONAL JOURNAL OF CANCER 130 1558-1566. .
-
Mazzolini R; Dopeso H; Mateo-Lozano S; Chang W; Rodrigues P; Bazzocco S; Alazzouzi H; Landolfi S; Hernández-Losa J; Andretta E; Alhopuro P; Espín E; Armengol M; Tabernero J; Ramón y Cajal S; Kloor M; Gebert J; Mariadason JM; Schwartz S; Aaltonen LA; Mooseker MS; Arango D
Brush border myosin Ia has tumor suppressor activity in the intestine.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 109 1530-1535. .
-
Dopeso H; Mateo-Lozano S; Elez E; Landolfi S; Ramos Pascual FJ; Hernández-Losa J; Mazzolini R; Rodrigues P; Bazzocco S; Carreras MJ; Espín E; Armengol M; Wilson AJ; Mariadason JM; Ramon Y Cajal S; Tabernero J; Schwartz S; Arango D
Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment.
CLINICAL CANCER RESEARCH 16 2375-2382. .
-
Wilson AJ; Chueh AC; Tögel L; Corner GA; Ahmed N; Goel S; Byun DS; Nasser S; Houston MA; Jhawer M; Smartt HJ; Murray LB; Nicholas C; Heerdt BG; Arango D; Augenlicht LH; Mariadason JM
Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.
CANCER RESEARCH 70 609-620. .
-
Yuan Z; Shin J; Wilson A; Goel S; Ling YH; Ahmed N; Dopeso H; Jhawer M; Nasser S; Montagna C; Fordyce K; Augenlicht LH; Aaltonen LA; Arango D; Weber TK; Mariadason JM
An A13 repeat within the 3'-untranslated region of epidermal growth factor receptor (EGFR) is frequently mutated in microsatellite instability colon cancers and is associated with increased EGFR expression.
CANCER RESEARCH 69 7811-7818. .
-
Jhawer M; Goel S; Wilson AJ; Montagna C; Ling YH; Byun DS; Nasser S; Arango D; Shin J; Klampfer L; Augenlicht LH; Perez-Soler R; Soler RP; Mariadason JM
PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab.
CANCER RESEARCH 68 1953-1961. .
-
Wilson AJ; Byun DS; Popova N; Murray LB; L'Italien K; Sowa Y; Arango D; Velcich A; Augenlicht LH; Mariadason JM
Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer.
Journal Of Biological Chemistry 281 13548-13558. .
-
Ropero S; Fraga MF; Ballestar E; Hamelin R; Yamamoto H; Boix-Chornet M; Caballero R; Alaminos M; Setien F; Paz MF; Herranz M; Palacios J; Arango D; Orntoft TF; Aaltonen LA; Schwartz S; Esteller M
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition.
Nature Genetics 38 566-569. .
-
Vanharanta S; Pollard PJ; Lehtonen HJ; Laiho P; Sjöberg J; Leminen A; Aittomäki K; Arola J; Kruhoffer M; Orntoft TF; Tomlinson IP; Kiuru M; Arango D; Aaltonen LA
Distinct expression profile in fumarate-hydratase-deficient uterine fibroids.
HUMAN MOLECULAR GENETICS 15 97-103. .
Proyectos
- CHEMBAR: Chemopreventive effects of barley-based foods rich
- Towards precision radiotherapy for rectal cancer patients Principal Investigator
- Contratos predoctorales de formación en investigación en salud (PFIS)
- Nueva aproximación terapéutica para el cáncer colorectal.
- EPH Receptor Signaling in Endometrial Cancer
- Antioxidant treatment as a novel therapeutic option for microvillus inclusion disease. ARMED
- Programa d'Impuls al Talent i l'Ocupabilitat (2021-2024)
- Nueva estrategia terapéutica para ael cáncer gástrico basada en la modulación de la señalización de RHOA
- Desarrollo de nanosistemas de marcaje de CXCR4 mediante radiosondas para la imagen molecular de células tumorales y del microambiente tumoral
- Identificación de nuevos biomarcadores de respuesta a los compuestos regorafenib y TAS-102 en pacientes con cáncer colorrectal.
- Targeting tumor microevironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy
